
Henopar AQ 75mg/ml Injection
Marketer
H & Care Incorp
Salt Composition
Diclofenac (75mg/ml)
Overview Henopar AQ 75mg/ml Injection
Aqueos Henopar 75mg/ml injection provides analgesic relief. Indicated for pain, inflammation, and stiffness associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma, it's administered intravenously when oral intake is infeasible. Injection must be given by a qualified medical practitioner; self-administration is strictly prohibited. Pre-existing cardiovascular conditions (e.g., heart disease, stroke) should be disclosed to your physician. Report any injection site irritation (pain, swelling, erythema) immediately. Common adverse effects include nausea, emesis, cephalgia, and local injection reactions. Prolonged therapy necessitates regular monitoring of renal and hepatic function, along with blood counts. Chronic use carries a risk of severe complications, including gastrointestinal hemorrhage and nephropathy.
Uses of Henopar AQ 75mg/ml Injection
Alleviation of discomfort
Major Benefits of Henopar AQ 75mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Henopar AQ 75mg/ml Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Henopar AQ 75mg/ml Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Henopar AQ 75mg/ml Injection works:
Henopar AQ 75mg/ml Injection, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and the associated signs of inflammation, such as redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Henopar AQ 75mg/ml Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Henopar AQ 75mg/ml Injection during gestation is contraindicated due to established fetal harm. Exceptions may exist in extreme circumstances where the physician deems the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Administration of Henopar AQ 75mg/ml Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Henopar AQ 75mg/ml Injection may result in adverse reactions that could impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Henopar AQ 75mg/ml Injection cautiously, as dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Henopar AQ 75mg/ml Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Henopar AQ 75mg/ml Injection :
Omit a Henopar AQ 75mg/ml Injection dose? Seek your physician's advice.
Facts to Know About Henopar AQ 75mg/ml Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic acid analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
